EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expanding the genotype–phenotype spectrum in hereditary colorectal cancer by gene panel testing

Anna Rohlin iD, Eva Rambech, Anders Kvist, Therese Törngren, Frida Eiengård, Ulf Lundstam, Theofanis Zagoras, Samuel Gebre-Medhin, Åke Borg, Jan Björk, Mef Nilbert, Margareta Nordling

Familial Cancer · 2017-04 · 16 (2) · 195-203

DOI: 10.1007/s10689-016-9934-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Familial Cancer, online erschienen am 30.09.2016. Verfasst von Anna Rohlin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Clinical Genetics, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. anna.ro…. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancerfonden, The Swedish state under the LUA/ALF agreement concerning research and education of doctors, Stiftelsen Assar Gabrielssons Fond.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hereditary syndromes causing colorectal cancer include both polyposis and non-polyposis syndromes. Overlapping phenotypes between the syndromes have been recognized and this make targeted molecular testing for single genes less favorable, instead there is a gaining interest for multi-gene panel-based approaches detecting both SNVs, indels and CNVs in the same assay. We applied a panel including 19 CRC susceptibility genes to 91 individuals of six phenotypic subgroups. Targeted NGS-based sequencing of the whole gene regions including introns of the 19 genes was used. The individuals had a family history of CRC or had a phenotype consistent with a known CRC syndrome. The purpose of the study was to demonstrate the diagnostic difficulties linked to genotype-phenotype diversity and the benefits of using a gene panel. Pathogenicity classification was carried out on 46 detected variants. In total we detected sixteen pathogenic or likely pathogenic variants and 30 variants of unknown clinical significance. Four of the pathogenic or likely pathogenic variants were found in BMPR1A in patients with unexplained familial adenomatous polyposis or atypical adenomatous polyposis, which extends the genotype-phenotype spectrum for this gene. Nine patients had more than one variant remaining after the filtration, including three with truncating mutations in BMPR1A, PMS2 and AXIN2. CNVs were found in three patients, in upstream regions of SMAD4, MSH3 and CTNNB1, and one additional individual harbored a 24.2 kb duplication in CDH1 intron1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenomatous Polyposis ColiAdolescentAdultAgedAged, 80 and overAntigens, CDAxin ProteinBone Morphogenetic Protein Receptors, Type ICadherinsColorectal Neoplasms, Hereditary NonpolyposisDNA Copy Number VariationsDNA-Binding ProteinsFemaleGenetic Predisposition to DiseaseGenetic TestingHigh-Throughput Nucleotide SequencingHumansIntronsMaleMiddle Aged

Stichwörter der Autor:innen

Colorectal cancerFAPFamilial adenomatous polyposisGene panelHereditaryLynch syndrome

Substanzen

AXIN2 protein, humanAntigens, CDAxin ProteinCDH1 protein, humanCTNNB1 protein, humanCadherinsDNA-Binding ProteinsMSH3 protein, humanMutS Homolog 3 ProteinSMAD4 protein, human

Autor:innen und Institutionen

  • Department of Molecular and Clinical Genetics, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. anna.rohlin@vgregion.se.
  • Division of Oncology and Pathology Department of Clinical Sciences Lund, Lund University, Medicon Village, 22381, Lund, Sweden.
  • Department of Molecular and Clinical Genetics, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Department of Surgery, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital/Östra, 416 85, Gothenburg, Sweden.
  • Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Department of Clinical Genetics, Office for Medical Services, Division of Laboratory Medicine, Lund, Sweden.

ORCID-Profile: Anna Rohlin

Förderung

  • Cancerfonden
  • The Swedish state under the LUA/ALF agreement concerning research and education of doctors
  • Stiftelsen Assar Gabrielssons Fond
  • Stiftelserna Wilhelm och Martina Lundgrens
  • The Health and Medical Care Committee of the Regional Executive Board, Region Västra Götaland, Project grant from Laboratory division Sahlgrenska University Ho…
  • The Nilsson-Ehle Fondation
  • The Sahlgrenska University Hospital Foundation

Zitieren

APA

Rohlin, A., Rambech, E., Kvist, A., Törngren, T., Eiengård, F., Lundstam, U., Zagoras, T., Gebre-Medhin, S., Borg, Å., Björk, J., Nilbert, M., & Nordling, M. (2017). Expanding the genotype–phenotype spectrum in hereditary colorectal cancer by gene panel testing. Familial Cancer, 16(2), 195-203. https://doi.org/10.1007/s10689-016-9934-0

Vancouver

Rohlin A, Rambech E, Kvist A, Törngren T, Eiengård F, Lundstam U, et al. Expanding the genotype–phenotype spectrum in hereditary colorectal cancer by gene panel testing. Familial Cancer. 2017;16(2):195-203. doi:10.1007/s10689-016-9934-0

BibTeX
@article{Rohlin2017,
  author = {Rohlin, Anna and Rambech, Eva and Kvist, Anders and Törngren, Therese and Eiengård, Frida and Lundstam, Ulf and Zagoras, Theofanis and Gebre-Medhin, Samuel and Borg, Åke and Björk, Jan and Nilbert, Mef and Nordling, Margareta},
  title = {Expanding the genotype–phenotype spectrum in hereditary colorectal cancer by gene panel testing},
  journal = {Familial Cancer},
  year = {2017},
  volume = {16},
  number = {2},
  pages = {195--203},
  doi = {10.1007/s10689-016-9934-0}
}
Kostenlos starten →